The global HIV response is at a crossroads. In 2024, the long-acting injectable lenacapavir was launched, a breakthrough prevention tool described by many as the closest thing to an HIV vaccine. Combined with a human-rights, community-centred approach, this innovation creates a realistic opportunity to end one of the world’s deadliest diseases within the next five years.
The UK has historically played a leading role in the global HIV response through multilateral funding and innovative partnerships that have saved millions of lives. The decisions the UK makes now in funding global health institutions like Unitaid, the Global Fund, UNAIDS, and the Robert Carr Fund (RCF), and in recommitting to domestic HIV leadership will determine whether this historic opportunity becomes reality.
That's why we are calling on the UK government to:
Lead politically and financially at the upcoming UN High-Level Meeting on HIV and AIDS, driving global commitment to end AIDS by 2030.
Prioritise funding to key global health institutions including Unitaid, the Global Fund, UNAIDS, and the Robert Carr Fund which are all critical competents of the global health architecture that make HIV prevention and treatment accessible.
Recommit to ending new HIV transmissions in the UK
Champion accessible and affordable innovations, like lenacapavir, combined with a human-rights, community-centred approach
The UK must lead again, both at home and globally, to end AIDS by 2030.